Opaleye Management Inc.
Q2 2025 13F Holdings
- Locationboston, MA
- Num holdings
41
- Value ($000)
$494,141
- Date Filed08/15/2025
- Form typerestatement
- CIK0001595855
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HARROW HEALTH INC | COM | 415858109 | $119.26M | 24 % | 3,905,000 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | $40.76M | 8 % | 2,860,000 | ||
IMMUNOME INC | COM | 45257U108 | $32.83M | 7 % | 3,529,581 | ||
SANUWAVE HEALTH INC | COM | 80303D305 | $32.2M | 7 % | 980,000 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | $30.84M | 6 % | 2,475,000 | ||
CODEXIS INC | COM | 192005106 | $30.74M | 6 % | 12,600,000 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $30.02M | 6 % | 475,000 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $19.25M | 4 % | 535,000 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | $14.8M | 3 % | 1,595,000 | ||
ARVINAS INC | COM | 04335A105 | $12.36M | 3 % | 1,680,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100